Published on
March 24, 2020

Champignon Brands

Champignon Brands Inc. is a publicly-traded research-driven company specializing in the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine industries.

Capital Snapshot:
Share Price: C$0.305
Shares Outstanding: 61,737,688
Market Cap: C$18.8M
52W Low/High: $0.18 / $0.45
Company Investor Presentation

Recent News:

  • Announced Normal Course Issuer Bid for up to 5% of the issued common shares of the company. Press Release
  • Entered in to Definitive Agreement to acquire Novo Formulations Ltd, a specialty biotechnology company focused on developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. Press Release
  • Entered in to Definitive Agreement to acquire Artisan Growers, a BC-based craft mushroom cultivator and supplier. Press Release

Champignon Brands has positioned themselves uniquely ahead of the curve in the Psychedelic and plant based products universe. With a flagship brand, Vitality SuperTeas, and the recent purchase of Artisan Growers, their wholly owned CPG product line is diverse and robust.

With the recent acquisitions of important IP around ketamine delivery systems, Champignon is establishing itself as a first mover in psychedelic medicine. Looking ahead, they are well capitalized to continue to find accretive deals around science, IP and innovation.